393 related articles for article (PubMed ID: 30047419)
1. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
Agarwal S
Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
[TBL] [Abstract][Full Text] [Related]
2. Telomere length in inherited bone marrow failure syndromes.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
[TBL] [Abstract][Full Text] [Related]
3. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
[TBL] [Abstract][Full Text] [Related]
4. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Hoffman H; Rice C; Skordalakes E
J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
[TBL] [Abstract][Full Text] [Related]
5. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Niewisch MR; Savage SA
Expert Rev Hematol; 2019 Dec; 12(12):1037-1052. PubMed ID: 31478401
[No Abstract] [Full Text] [Related]
6. Dyskeratosis congenita and telomere biology disorders.
Savage SA
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):637-648. PubMed ID: 36485133
[TBL] [Abstract][Full Text] [Related]
7. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
Du HY; Pumbo E; Ivanovich J; An P; Maziarz RT; Reiss UM; Chirnomas D; Shimamura A; Vlachos A; Lipton JM; Goyal RK; Goldman F; Wilson DB; Mason PJ; Bessler M
Blood; 2009 Jan; 113(2):309-16. PubMed ID: 18931339
[TBL] [Abstract][Full Text] [Related]
8. Dyskeratosis congenita, stem cells and telomeres.
Kirwan M; Dokal I
Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
[TBL] [Abstract][Full Text] [Related]
9. The shelterin complex and hematopoiesis.
Jones M; Bisht K; Savage SA; Nandakumar J; Keegan CE; Maillard I
J Clin Invest; 2016 May; 126(5):1621-9. PubMed ID: 27135879
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in dyskeratosis congenita.
Nishio N; Kojima S
Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
[TBL] [Abstract][Full Text] [Related]
11. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
Beier F; Foronda M; Martinez P; Blasco MA
Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
[TBL] [Abstract][Full Text] [Related]
12. Refining the phenotype associated with biallelic DNAJC21 mutations.
D'Amours G; Lopes F; Gauthier J; Saillour V; Nassif C; Wynn R; Alos N; Leblanc T; Capri Y; Nizard S; Lemyre E; Michaud JL; Pelletier VA; Pastore YD; Soucy JF
Clin Genet; 2018 Aug; 94(2):252-258. PubMed ID: 29700810
[TBL] [Abstract][Full Text] [Related]
13. Paroxysmal nocturnal hemoglobinuria clones are not infrequent in patients with inherited bone marrow failure syndromes.
Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Sood A; Bose P; Varma S
Eur J Haematol; 2017 Aug; 99(2):194-195. PubMed ID: 28452421
[No Abstract] [Full Text] [Related]
14. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
[TBL] [Abstract][Full Text] [Related]
15. Acquired and Inherited Bone Marrow Failure Syndromes.
Sieff CA
Hematol Oncol Clin North Am; 2018 Aug; 32(4):xiii-xiv. PubMed ID: 30047424
[No Abstract] [Full Text] [Related]
16. Introduction to Acquired and Inherited Bone Marrow Failure.
Sieff CA
Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology?
Rackley S; Pao M; Seratti GF; Giri N; Rasimas JJ; Alter BP; Savage SA
Psychosomatics; 2012; 53(3):230-5. PubMed ID: 22458992
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow failure and the new telomere diseases: practice and research.
Young NS
Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
[TBL] [Abstract][Full Text] [Related]
19. Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.
Khincha PP; Bertuch AA; Gadalla SM; Giri N; Alter BP; Savage SA
Blood Adv; 2018 Jun; 2(11):1243-1249. PubMed ID: 29853525
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
